Reference number : 236-2018-2019-Q2-00111, amendment number : , agreement type : G, recipient legal name : So, Alan I, recipient country : CA, recipient province : BC, recipient city : Vancouver, recipient postal code : V6T 1Z1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 60000.0, agreement start date : 2018-09-01, agreement end date : 2021-08-31, description english : YB-1 in the development of sunitinib-resistance in metastatic clear cell renal cell carcinoma., description french : YB-1 in the development of sunitinib-resistance in metastatic clear cell renal cell carcinoma., expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada